Doxorubicin Hydrochloride
Records for this ingredient, by country (identity only).
ATC L01DB01 · 5 markets · 36 records
AU 10 records · 4 shown of 4
- 2 mg/mL per mL / per unit basis not statedinjectionADRIAMYCIN doxorubicin hydrochloride 10mg/5mL injection vialDOXORUBICIN ACCORD doxorubicin hydrochloride 200 mg/100 mL concentrated solution for injection vial、Doxorubicin Solution for Injection 50 mg/25 mL vial、LIPOSOMAL DOXORUBICIN SUN Doxorubicin Hydrochloride 20mg/10mL Liposome Injection concentrate glass vial
- 50 mg per mL / per unit basis not statedinjectionCAELYX doxorubicin hydrochloride 20 mg/10 mL concentrated injection vial
- 10 mg per mL / per unit basis not statedinjectionDOXORUBICIN ACCORD doxorubicin hydrochloride 10mg/5ml concentrated solution for
- 20 mg per mL / per unit basis not statedinjectionCAELYX doxorubicin hydrochloride 20 mg/10 mL concentrated injection vial
FR 8 records · 4 shown of 4
- 2 mg/1 mLinjectionCAELYX PEGYLATED LIPOSOMAL 2 mg/ml, solution à diluer pour perfusionDOXORUBICINE ACCORD 2 mg/ml, solution pour perfusion、DOXORUBICINE ARROW 2 mg/mL, solution pour perfusion、ZOLSKETIL PEGYLATED LIPOSOMAL 2 mg/mL, dispersion à diluer pour perfusion
- 50 mg per mL / per unit basis not statedinjectionADRIBLASTINE 10 mg, poudre pour solution injectable en flaconDOXORUBICINE TEVA 10 mg/5 ml, solution injectable
- 10 mg per mL / per unit basis not statedinjectionADRIBLASTINE 10 mg, poudre pour solution injectable en flacon
- 10 mg/5 mLinjectionDOXORUBICINE TEVA 10 mg/5 ml, solution injectable
SG 7 records · 2 shown of 2
- 2 mg/mL per mL / per unit basis not statedinjectionADRIM – DOXORUBICIN HYDROCHLORIDE INJECTION USP 2MG/MLCAELYX CONCENTRATE FOR INFUSION 2 mg/ml、CHEMODOX CONCENTRATE FOR INFUSION 2MG/ML、DOXABIN INJECTION 2MG/ML、DOXOCCORD CONCENTRATE FOR SOLUTION FOR INFUSION 2 MG/ML、DOXORUBICIN ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 2MG/ML
- 2 mg per mL / per unit basis not statedinjectionEbedoxo 2mg/ml
HK 7 records · 0 shown of 0
7 records · 0 manufacturers 7 registros · 0 fabricantes 7 个记录 · 0 个厂家 7 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
EU 3 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.
| Strength / form / release | AU | SG | HK | EU | FR |
|---|---|---|---|---|---|
| 2 mg/mL per mL / per unit basis not stated cannot compare injection | ADRIAMYCIN doxorubicin hydrochloride 10mg/5mL injection vial DOXORUBICIN ACCORD doxorubicin hydrochloride 200 mg/100 mL concentrated solution for injection vial Doxorubicin Solution for Injection 50 mg/25 mL vial+1LIPOSOMAL DOXORUBICIN SUN Doxorubicin Hydrochloride 20mg/10mL Liposome Injection concentrate glass vial | ADRIM – DOXORUBICIN HYDROCHLORIDE INJECTION USP 2MG/ML CAELYX CONCENTRATE FOR INFUSION 2 mg/ml CHEMODOX CONCENTRATE FOR INFUSION 2MG/ML+3DOXABIN INJECTION 2MG/ML DOXOCCORD CONCENTRATE FOR SOLUTION FOR INFUSION 2 MG/ML DOXORUBICIN ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 2MG/ML | |||
| 2 mg/1 mL injection | CAELYX PEGYLATED LIPOSOMAL 2 mg/ml, solution à diluer pour perfusion DOXORUBICINE ACCORD 2 mg/ml, solution pour perfusion DOXORUBICINE ARROW 2 mg/mL, solution pour perfusion+1ZOLSKETIL PEGYLATED LIPOSOMAL 2 mg/mL, dispersion à diluer pour perfusion | ||||
| 50 mg per mL / per unit basis not stated cannot compare injection | CAELYX doxorubicin hydrochloride 20 mg/10 mL concentrated injection vial | ADRIBLASTINE 10 mg, poudre pour solution injectable en flacon DOXORUBICINE TEVA 10 mg/5 ml, solution injectable | |||
| 10 mg per mL / per unit basis not stated cannot compare injection | DOXORUBICIN ACCORD doxorubicin hydrochloride 10mg/5ml concentrated solution for | ADRIBLASTINE 10 mg, poudre pour solution injectable en flacon | |||
| 20 mg per mL / per unit basis not stated cannot compare injection | CAELYX doxorubicin hydrochloride 20 mg/10 mL concentrated injection vial | ||||
| 10 mg/5 mL injection | DOXORUBICINE TEVA 10 mg/5 ml, solution injectable | ||||
| 2 mg per mL / per unit basis not stated cannot compare injection | Ebedoxo 2mg/ml | ||||
unknown | CAELYX CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/10ML DOXOCCORD LP CONCENTRATE FOR DISPERSION FOR INFUSION 20MG/10ML DOXORUBICIN HYDROCHLORIDE LIPOSOME CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/10ML+2DOXORUBICIN-EBEWE INJ 10MG/5ML VIAL DOXORUBICIN-TEVA INJ 2MG/ML | CAELYX PEGYLATED LIPOSOMAL Celdoxome pegylated liposomal Doxolipad |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in HK · EU and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en HK · EU que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 HK · EU 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 HK · EU 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.